| Date Filed | Type | Description |
| 09/08/2022 |
SC 13G
| Vivo Opportunity, LLC reports a 7.1% stake in Astria Therapeutics, Inc. |
| 04/08/2022 |
SC 13G
| Vivo Opportunity, LLC reports a 5.9% stake in Geron Corporation |
| 02/11/2022 |
SC 13G/A
| Vivo Opportunity, LLC reports a 4.1% stake in Avadel Pharmaceuticals plc |
| 09/30/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/11/2020 |
SC 13G
| Vivo Opportunity, LLC reports a 4.8% stake in Verastem, Inc. |
| 03/04/2020 |
SC 13G
| Vivo Opportunity, LLC reports a 6.2% stake in Avadel Pharmaceuticals plc |
| 02/13/2020 |
SC 13G/A
| Vivo Opportunity, LLC reports a 0% stake in Acer Therapeutics Inc. |
| 02/13/2020 |
SC 13G/A
| Vivo Opportunity, LLC reports a 10% stake in MEI Pharma, Inc. |
| 02/13/2020 |
SC 13G/A
| Vivo Opportunity, LLC reports a 2.9% stake in Xenon Pharmaceuticals Inc. |
| 11/25/2019 |
SC 13G
| Vivo Opportunity, LLC reports a 15.1% stake in Sierra Oncology, Inc. |
| 04/12/2019 |
SC 13G
| Vivo Opportunity, LLC reports a 5.8% stake in Chiasma, Inc. |
| 03/26/2019 |
SC 13G
| Vivo Opportunity, LLC reports a 4.8% stake in Matinas BioPharma Holdings, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/17/2018 |
SC 13G
| Vivo Opportunity, LLC reports a 5.3% stake in Acer Therapeutics Inc. |
| 07/13/2018 |
SC 13G
| Vivo Opportunity, LLC reports a 5.6% stake in Xenon Pharmaceuticals Inc. |
| 01/26/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |